ACP Issues Guidance Statement on CRC Screening of Average-risk Adults
The American College of Physicians today issued a guidance statement for routine colorectal cancer screening for average-risk adults.
Drug Use & Treatment by State: The Best and Worst
The worst state for drug sales on school grounds? The best state for detox and rehab facilities? Test your best guess with these and 6 more best/worst comparisons.
Depression Screening/Treatment after ACS Yields No Benefit
Screening for depression among ACS patients is widely recommended by professional guidelines, but a new study suggests little return on the investment.
Dapagliflozin Approved to Reduce Risk of Hospitalization for Heart Failure in T2D
The SGLT2 inhibitor, on October 21, 2019 was granted a label expansion from FDA for the prevention of hospitalization for heart failure in patients with T2D.
FDA Approves First-in-class Oral Agent for Adults with Migraine
Lasmitidan is the first 5-HT1F receptor agonist to receive FDA approval and was found superior to placebo for reduction of migraine pain and most bothersome symptom at 2 hours.
Motivational Interviewing: A Brief Introduction
Motivational interviewing uses the common human problem of ambivalence about change to help clients shape their own solutions.
Glycemic Control Improves with Motivational Texts
For people with type 2 diabetes, receiving motivational messages via mobile text was associated with reduced A1c vs patients who received usual care.
Three Major Retail Chains Suspend Zantac Sales
CVS, Walgreens, and Rite Aid have all taken branded and generic ranitidine products off shelves as FDA continues to investigate contamination with a suspected carcinogen.
CDC Updates to Flu Vaccination Guidance, 2019-2020
The CDC made important changes to its flu vaccination recommendations for 2019-2020. Here is a quick review.
Canagliflozin Approved to Slow CKD Progression in T2D
The SGLT-2 inhibitor canagliflozin was FDA-approved on September 30, 2019, to slow progression of diabetic kidney disease and reduce risk of heart failure hospitalization.
Where Do the Highest- & Lowest-paid US Physicians Work?
Physician salaries vary widely across US cities, among specialties, and between men and women. Find out if you're in touch with the compensation pulse.
Less Bleeding Seen with Ticagrelor Monotherapy at 3 Months post-PCI vs DAPT
Lower bleeding rates but no increase in risk of death, MI, or stroke topped results reported from the TWIGHLIGHT study which compared ticagrelor monotherapy at 3 months post-PCI vs ticarelor plus aspirin.
FDA Approves First Oral GLP-1 Receptor Agonist for T2D
Oral semaglutide, the first oral GLP-1 receptor agonsist, was approved by the FDA on Sept 20, 2019, becoming the only noninjectable formulation in the class.
Novartis' Sandoz Unit Halts Zantac Distribution
Contamination of some lots of ranitidine (Zantac) led the Novartis Sandoz unit today to stop distribution of the drug while the issue is being investigated.
Health of US Diabetes Patients Largely Unchanged since 2005
US adults with type 2 diabetes have acheived negligible change in blood glucose levels, blood pressure, LDL-C levels, and smoking status in the past 15 years, according to a new study.
PCPs are Missing Prediabetes, Survey Finds
Less than half of PCPs responding to a recent survey chose correct values for prediabetes screening tests and seemed unaware of other evidence-based recommendations for prediabetes.
US Diabetes Treatment is Missing the Mark
US adults with diagnosed diabetes are no closer to treatment goals than they were in 2005, according to a new study.
Smoking Cessation and CVD Risk: 5 Years and All Clear?
Heavy smokers who quit remain at significantly increased CVD risk for up to 10 years or more, according to new research. Results suggest that current risk estimators may need revision.
Fear a Future with Fentanyl
Deaths related to synthetic opioids increased from approximately 3000 in 2013 to more than 30 000 in 2018. A new book warns there is more to come.
Diabetes Drug Costs Force Patients to Cut Corners
About 25% of patients with diabetes report asking a physician for a cheaper drug. Skipping doses and pill splitting are tactics used to cut costs.
Vaping-related Respiratory Disease Requires Intubation for Some
Recent vaping behavior is the only commonality found among teens and young adults hospitalized in 2 midwestern states, for severe respiratory symptoms.
Mass Shootings Condemned by Leading US Physician Organizations
The Dayton and El Paso tragedies bring yet another urgent call to action against gun violence from a consortium of the leading US physician and public health organizations.
World Experts to Discuss Future of Neurology at Inaugural International Congress
The first annual International Congress on the Future of Neurology convenes in New York City in September. Which thought leaders will be moderating?
Sobering Report on Binge Drinking in Older Adults
One out of 10 US adults aged ≥ 65 years is a "current binge drinker," a new study found. It is sobering data and a call to action for primary care.
Your Patients May Lie to You, But Why?
Ever wonder if your patient is a "liar, liar, pants on fire"? Take this 5-question quiz on a new survey to find out if your suspicions are true.
Activity Guidelines Don't Motivate Americans
Americans still don't meet guideline-recommended physical activity levels even while sedentary behavior increases, according to a new NHANES analysis.
Needle-free Hypoglycemia Treatment Approved
The novel intranasal glucagon delivered with a portable, single-use device could simplify treatment of this dangerous side effect of antidiabetes medications.
AHA's "Life's Simple 7" Reduces Heart Failure Risk
Study: "Ideal" adherence to healhty habits (eg, weight control, no smoking, average A1c) may reduce risk of heart failure by >50% vs "inadequate" adherence.
Neuromodulators for Migraine At-a-Glance
Here: A snapshot of the 4 FDA-approved neuromodulation devices and a primer on neuromodulation for migraine at work.
10 CBD Company Health Claims: Please Read
FDA on July 23rd issued a warning letter to CBD-producer Curaleaf, Inc, citing unsubstantiated health claims for its products. Here are 10 of the claims your patients are reading.
